DAFNA Capital Management’s Spero Therapeutics SPRO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-125,000
| Closed | -$90K | – | 81 |
|
|
2025
Q1 | $90K | Hold |
125,000
| – | – | 0.03% | 82 |
|
|
2024
Q4 | $129K | Hold |
125,000
| – | – | 0.03% | 82 |
|
|
2024
Q3 | $168K | Hold |
125,000
| – | – | 0.04% | 83 |
|
|
2024
Q2 | $163K | Hold |
125,000
| – | – | 0.04% | 82 |
|
|
2024
Q1 | $215K | Hold |
125,000
| – | – | 0.05% | 71 |
|
|
2023
Q4 | $184K | Hold |
125,000
| – | – | 0.04% | 71 |
|
|
2023
Q3 | $151K | Hold |
125,000
| – | – | 0.05% | 72 |
|
|
2023
Q2 | $181K | Hold |
125,000
| – | – | 0.05% | 72 |
|
|
2023
Q1 | $181K | Hold |
125,000
| – | – | 0.05% | 70 |
|
|
2022
Q4 | $216K | Hold |
125,000
| – | – | 0.06% | 73 |
|
|
2022
Q3 | $250K | Buy |
+125,000
| New | +$250K | 0.07% | 83 |
|
|
2020
Q4 | – | Sell |
-100,000
| Closed | -$1.12M | – | 83 |
|
|
2020
Q3 | $1.12M | Buy |
+100,000
| New | +$1.12M | 0.36% | 55 |
|
|
2020
Q2 | – | Sell |
-48,103
| Closed | -$389K | – | 91 |
|
|
2020
Q1 | $389K | Buy |
+48,103
| New | +$389K | 0.16% | 70 |
|
|
2019
Q4 | – | Sell |
-39,395
| Closed | -$418K | – | 86 |
|
|
2019
Q3 | $418K | Sell |
39,395
-30,605
| -44% | -$325K | 0.16% | 74 |
|
|
2019
Q2 | $806K | Hold |
70,000
| – | – | 0.3% | 62 |
|
|
2019
Q1 | $897K | Hold |
70,000
| – | – | 0.39% | 55 |
|
|
2018
Q4 | $431K | Hold |
70,000
| – | – | 0.21% | 59 |
|
|
2018
Q3 | $736K | Buy |
+70,000
| New | +$736K | 0.3% | 56 |
|
|
2018
Q2 | – | Sell |
-29,544
| Closed | -$421K | – | 83 |
|
|
2018
Q1 | $421K | Buy |
29,544
+24,544
| +491% | +$350K | 0.2% | 62 |
|
|
2017
Q4 | $59K | Buy |
+5,000
| New | +$59K | 0.03% | 72 |
|